Page last updated: 2024-08-07 15:45:56
Mineralocorticoid receptor
A mineralocorticoid receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08235]
Synonyms
MR;
Nuclear receptor subfamily 3 group C member 2
Research
Bioassay Publications (59)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (6.78) | 18.2507 |
2000's | 18 (30.51) | 29.6817 |
2010's | 34 (57.63) | 24.3611 |
2020's | 3 (5.08) | 2.80 |
Compounds (22)
Drugs with Potency Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
mifepristone | Homo sapiens (human) | Potency | 1.0000 | 1 | 1 |
onapristone | Homo sapiens (human) | Potency | 1.0000 | 1 | 1 |
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
prednisolone | Homo sapiens (human) | IC50 | 0.0322 | 5 | 5 |
prednisolone | Homo sapiens (human) | Ki | 0.0186 | 2 | 2 |
spironolactone | Homo sapiens (human) | IC50 | 0.0315 | 13 | 13 |
spironolactone | Homo sapiens (human) | Ki | 0.0037 | 2 | 2 |
aldosterone | Homo sapiens (human) | IC50 | 0.0048 | 2 | 2 |
medroxyprogesterone acetate | Homo sapiens (human) | IC50 | 1.1970 | 3 | 3 |
dihydrotestosterone | Homo sapiens (human) | IC50 | 0.3600 | 1 | 1 |
mifepristone | Homo sapiens (human) | IC50 | 2.5337 | 10 | 13 |
mifepristone | Homo sapiens (human) | Ki | 3.8303 | 3 | 3 |
metribolone | Homo sapiens (human) | Ki | 0.0005 | 1 | 1 |
eplerenone | Homo sapiens (human) | IC50 | 0.6680 | 16 | 16 |
eplerenone | Homo sapiens (human) | Ki | 0.1259 | 1 | 1 |
fluticasone propionate | Homo sapiens (human) | IC50 | 0.1490 | 1 | 1 |
pulmicort | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
onapristone | Homo sapiens (human) | IC50 | 0.8233 | 3 | 3 |
pregna-4,17-diene-3,16-dione | Homo sapiens (human) | IC50 | 0.6600 | 2 | 2 |
pregna-4,17-diene-3,16-dione | Homo sapiens (human) | Ki | 0.0390 | 1 | 1 |
pregna-4,17-diene-3,16-dione, (17z)-isomer | Homo sapiens (human) | IC50 | 1.8800 | 1 | 1 |
pregna-4,17-diene-3,16-dione, (17z)-isomer | Homo sapiens (human) | Ki | 0.0370 | 1 | 1 |
asoprisnil | Homo sapiens (human) | IC50 | 1.6000 | 2 | 2 |
zk 216348 | Homo sapiens (human) | IC50 | 0.0587 | 2 | 2 |
fluticasone furoate | Homo sapiens (human) | IC50 | 0.1660 | 1 | 1 |
way-362450 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
mebudipine | Homo sapiens (human) | IC50 | 0.1260 | 2 | 2 |
lgd 2226 | Homo sapiens (human) | Ki | 1.0000 | 1 | 1 |
pf-03882845 | Homo sapiens (human) | IC50 | 0.0120 | 3 | 4 |
bay 94-8862 | Homo sapiens (human) | IC50 | 0.0275 | 4 | 4 |
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
spironolactone | Homo sapiens (human) | Kb | 0.0177 | 1 | 1 |
mifepristone | Homo sapiens (human) | Kif | 0.0100 | 1 | 1 |
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.Journal of medicinal chemistry, , 03-08, Volume: 61, Issue:5, 2018
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators.Bioorganic & medicinal chemistry letters, , 12-01, Volume: 26, Issue:23, 2016
Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design.Journal of medicinal chemistry, , Feb-13, Volume: 57, Issue:3, 2014
Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 24, Issue:8, 2014
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-Journal of medicinal chemistry, , Oct-27, Volume: 54, Issue:20, 2011
Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 21, Issue:22, 2011
Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.Journal of medicinal chemistry, , Sep-23, Volume: 53, Issue:18, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists.Journal of medicinal chemistry, , Dec-09, Volume: 53, Issue:23, 2010
Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: selective quinoline derivatives with prednisolone-equivalent functional activity.Journal of medicinal chemistry, , Aug-30, Volume: 44, Issue:18, 2001
Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1Journal of medicinal chemistry, , 10-13, Volume: 65, Issue:19, 2022
Discovery of Apararenone (MT-3995) as a Highly Selective, Potent, and Novel Nonsteroidal Mineralocorticoid Receptor Antagonist.Journal of medicinal chemistry, , 06-23, Volume: 65, Issue:12, 2022
[no title available]Journal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
Discovery of novel non-steroidal reverse indole mineralocorticoid receptor antagonists.Bioorganic & medicinal chemistry letters, , 06-15, Volume: 26, Issue:12, 2016
Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione series.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 24, Issue:7, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.Bioorganic & medicinal chemistry, , Oct-01, Volume: 22, Issue:19, 2014
Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 23, Issue:15, 2013
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.Journal of medicinal chemistry, , Dec-22, Volume: 54, Issue:24, 2011
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144.Journal of natural products, , Volume: 72, Issue:11, 2009
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.Journal of medicinal chemistry, , Dec-27, Volume: 50, Issue:26, 2007
Discovery of (Journal of medicinal chemistry, , 07-28, Volume: 65, Issue:14, 2022
Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.MedChemComm, , Aug-01, Volume: 10, Issue:8, 2019
Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs).European journal of medicinal chemistry, , Sep-05, Volume: 157, 2018
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.Journal of medicinal chemistry, , 04-13, Volume: 60, Issue:7, 2017
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 24, Issue:22, 2014
Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.Journal of medicinal chemistry, , Oct-14, Volume: 53, Issue:19, 2010
The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144.Journal of natural products, , Volume: 72, Issue:11, 2009
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.Journal of medicinal chemistry, , Sep-11, Volume: 46, Issue:19, 2003
5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.Journal of medicinal chemistry, , Jan-29, Volume: 41, Issue:3, 1998
5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.Journal of medicinal chemistry, , Oct-22, Volume: 41, Issue:22, 1998
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.Journal of medicinal chemistry, , Aug-27, Volume: 58, Issue:16, 2015
Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists.Bioorganic & medicinal chemistry, , Jun-15, Volume: 18, Issue:12, 2010
1-Methyl-1H-pyrrole-2-carbonitrile containing tetrahydronaphthalene derivatives as non-steroidal progesterone receptor antagonists.Bioorganic & medicinal chemistry letters, , Aug-15, Volume: 20, Issue:16, 2010
7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.Bioorganic & medicinal chemistry, , Jul-01, Volume: 16, Issue:13, 2008
1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 18, Issue:18, 2008
Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators.Journal of medicinal chemistry, , Aug-11, Volume: 48, Issue:16, 2005
Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.Journal of medicinal chemistry, , Aug-12, Volume: 47, Issue:17, 2004
Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists.Bioorganic & medicinal chemistry letters, , May-03, Volume: 14, Issue:9, 2004
Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore.Bioorganic & medicinal chemistry letters, , Jun-16, Volume: 13, Issue:12, 2003
Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists.Journal of medicinal chemistry, , Jun-06, Volume: 45, Issue:12, 2002
6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.Journal of medicinal chemistry, , Sep-26, Volume: 45, Issue:20, 2002
Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.Journal of medicinal chemistry, , Aug-27, Volume: 41, Issue:18, 1998
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.Journal of medicinal chemistry, , Apr-26, Volume: 39, Issue:9, 1996
Discovery of Apararenone (MT-3995) as a Highly Selective, Potent, and Novel Nonsteroidal Mineralocorticoid Receptor Antagonist.Journal of medicinal chemistry, , 06-23, Volume: 65, Issue:12, 2022
[no title available]Journal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
Discovery of novel non-steroidal reverse indole mineralocorticoid receptor antagonists.Bioorganic & medicinal chemistry letters, , 06-15, Volume: 26, Issue:12, 2016
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.Journal of medicinal chemistry, , May-22, Volume: 57, Issue:10, 2014
Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione series.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 24, Issue:7, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.Bioorganic & medicinal chemistry, , Oct-01, Volume: 22, Issue:19, 2014
Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 23, Issue:15, 2013
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.Journal of medicinal chemistry, , Dec-22, Volume: 54, Issue:24, 2011
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.Journal of medicinal chemistry, , May-27, Volume: 53, Issue:10, 2010
Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases.Journal of medicinal chemistry, , 06-14, Volume: 61, Issue:11, 2018
Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.Journal of medicinal chemistry, , 10-26, Volume: 60, Issue:20, 2017
Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore.Bioorganic & medicinal chemistry letters, , Jun-16, Volume: 13, Issue:12, 2003
Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines.Bioorganic & medicinal chemistry letters, , Mar-06, Volume: 10, Issue:5, 2000
Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.Journal of medicinal chemistry, , Aug-27, Volume: 41, Issue:18, 1998
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.Journal of medicinal chemistry, , Apr-26, Volume: 39, Issue:9, 1996
Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.MedChemComm, , Aug-01, Volume: 10, Issue:8, 2019
Is antagonism of E/Z-guggulsterone at the farnesoid X receptor mediated by a noncanonical binding site? A molecular modeling study.Journal of medicinal chemistry, , Nov-03, Volume: 48, Issue:22, 2005
Novel progesterone receptor modulators: 4-aryl-phenylsulfonamides.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 22, Issue:23, 2012
Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Discovery of quinolines as selective glucocorticoid receptor agonists.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 20, Issue:19, 2010
Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists.Journal of medicinal chemistry, , Dec-28, Volume: 49, Issue:26, 2006
Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases.Journal of medicinal chemistry, , 06-14, Volume: 61, Issue:11, 2018
Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.Journal of medicinal chemistry, , 10-26, Volume: 60, Issue:20, 2017
Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.Journal of medicinal chemistry, , May-27, Volume: 53, Issue:10, 2010
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.Journal of medicinal chemistry, , May-22, Volume: 57, Issue:10, 2014
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.Journal of medicinal chemistry, , 04-13, Volume: 60, Issue:7, 2017
Microwave-assisted synthesis of pyrimido[4,5-b][1,6]naphthyridin-4(3H)-ones with potential antitumor activity.European journal of medicinal chemistry, , Volume: 60, 2013
Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy.Journal of medicinal chemistry, , Sep-27, Volume: 55, Issue:18, 2012
Enables
This protein enables 10 target(s):
Target | Category | Definition |
DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA-binding transcription factor activity | molecular function | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. [GOC:txnOH-2018] |
nuclear steroid receptor activity | molecular function | Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function. [GOC:signaling, PMID:14708019] |
steroid binding | molecular function | Binding to a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene. [GOC:jl, ISBN:0198506732] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
TBP-class protein binding | molecular function | Binding to a member of the class of TATA-binding proteins (TBP), including any of the TBP-related factors (TRFs). [GOC:jl, GOC:txnOH, http://www.mblab.gla.ac.uk/, PMID:16858867] |
sequence-specific double-stranded DNA binding | molecular function | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. [GOC:dos, GOC:sl] |
nuclear receptor activity | molecular function | A DNA-binding transcription factor activity regulated by binding to a ligand that modulates the transcription of specific gene sets transcribed by RNA polymerase II. Nuclear receptor ligands are usually lipid-based (such as a steroid hormone) and the binding of the ligand to its receptor often occurs in the cytosol, which leads to its translocation to the nucleus. [GOC:txnOH-2018, PMID:23457262] |
estrogen response element binding | molecular function | Binding to an estrogen response element (ERE), a conserved sequence found in the promoters of genes whose expression is regulated in response to estrogen. [GOC:ecd, PMID:15036253, PMID:17975005] |
Located In
This protein is located in 3 target(s):
Target | Category | Definition |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
Part Of
This protein is part of 2 target(s):
Target | Category | Definition |
chromatin | cellular component | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130] |
receptor complex | cellular component | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. [GOC:go_curators] |
Involved In
This protein is involved in 4 target(s):
Target | Category | Definition |
signal transduction | biological process | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. [GOC:go_curators, GOC:mtg_signaling_feb11] |
positive regulation of non-canonical NF-kappaB signal transduction | biological process | Any process that activates or increases the frequency, rate or extent of the non-canonical NF-kappaB cascade. [GOC:TermGenie] |
regulation of transcription by RNA polymerase II | biological process | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
intracellular steroid hormone receptor signaling pathway | biological process | The series of molecular signals initiated by a steroid binding to an intracellular steroid hormone receptor. [GOC:mah, GOC:signaling] |